PDCD1 and colorectal carcinoma: [224] conducted an extensive metagenomic analysis to reveal that a higher prevalence of Fusobacterium nucleatum (F. nucleatum) in CRC patients was correlated with a lower responsive rate to PD‐1 blockade (Figure 6A).